SPONSOR
Samsung Medical Center
Total Trials
19
Recruiting
19
Phases
Phase 2, Phase 4, Phase 3, Phase 1, Phase 2
Conditions studied: Solid Tumor, AdultGastric AdenocarcinomaStomach NeoplasmsLocally Advanced Gastric CancerUnresectable Gastric CancerPancreas CancerCholangiocarcinomaGallbladder CancerCoronary Artery DiseaseChronic Coronary Syndrome
Samsung Medical Center is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Solid Tumor, Adult, Gastric Adenocarcinoma, Stomach Neoplasms, Locally Advanced Gastric Cancer.
The trial portfolio spans Phase 2, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Samsung Medical Center
How many clinical trials has Samsung Medical Center sponsored?
ClinicalMetric currently tracks 19 clinical trials sponsored by Samsung Medical Center, of which 19 are actively recruiting participants. These trials cover conditions including Solid Tumor, Adult, Gastric Adenocarcinoma, Stomach Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Samsung Medical Center research focus on?
Samsung Medical Center clinical trials span Solid Tumor, Adult, Gastric Adenocarcinoma, Stomach Neoplasms, Locally Advanced Gastric Cancer, Unresectable Gastric Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Samsung Medical Center clinical trial?
To participate in a Samsung Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Samsung Medical Center trials with current recruitment status updated daily.
Clinical Trials by Samsung Medical Center
NCT06383884 Phase 2
Recruiting
Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Solid Tumor, Adult
NCT07607119
Recruiting
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
Gastric Adenocarcinoma
NCT03637569
Recruiting
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Pancreas Cancer
NCT04014803 Phase 4
Recruiting
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Coronary Artery Disease
NCT06742931
Recruiting
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2
Chronic Coronary Syndrome
NCT07370623
Recruiting
Development of an AI Assessment System for Pediatric Respiratory Distress : A Prospective Study
Pediatric Respiratory Distress
NCT06259162
Recruiting
LAG3 Expression in Triple Negative Breast Cancer
Triple Negative Breast Cancer
NCT07803081
Recruiting
Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission
Breast Cancer
NCT06467097 Phase 3
Recruiting
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Kidney Neoplasm
NCT07447297
Recruiting
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
Atrial Fibrillation (AF)
NCT07638176
Recruiting
Effect of Individualized Positive End-expiratory Pressure (PEEP) in Patients Who Have an Intrinsic PEEP During One-lung Ventilation
Pulmonary Disease (COPD), Chronic Obstructive
NCT05527717 Phase 4
Recruiting
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Cardiogenic Shock
NCT02798731
Recruiting
Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Cardiac Allograft Vasculopathy
NCT06552559 Phase 1, Phase 2
Recruiting
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
B-cell Lymphoma Recurrent
NCT07911280 Phase 2
Recruiting
A Phase II, Trial of Neoadjuvant Trastuzumab + Durvalumab + FLOT Targeted Immunochemotherapy
Gastric Cancer
NCT05566249
Recruiting
A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
Rectal Cancer
NCT07190573
Recruiting
Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE)
Head and Neck Cancer
NCT07482865
Recruiting
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Cardiogenic Shock
NCT02798705
Recruiting
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Cardiac Amyloidosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology